Page last updated: 2024-10-30

meprobamate and Anorexia Nervosa

meprobamate has been researched along with Anorexia Nervosa in 1 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Anorexia Nervosa: An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lipman, RS1
Uhlenhuth, EH1
Rickels, K1
Covi, L1

Trials

1 trial available for meprobamate and Anorexia Nervosa

ArticleYear
Medication attitudes and drug response.
    Diseases of the nervous system, 1969, Volume: 30, Issue:7

    Topics: Anorexia Nervosa; Anxiety; Atropine; Attitude; Attitude of Health Personnel; Clinical Trials as Topi

1969